These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 26949038)
21. Withaferin A induces mitochondrial-dependent apoptosis in non-small cell lung cancer cells via generation of reactive oxygen species. Liu X; Chen L; Liang T; Tian XD; Liu Y; Zhang T J BUON; 2017; 22(1):244-250. PubMed ID: 28365961 [TBL] [Abstract][Full Text] [Related]
22. Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway. Leone A; Roca MS; Ciardiello C; Terranova-Barberio M; Vitagliano C; Ciliberto G; Mancini R; Di Gennaro E; Bruzzese F; Budillon A Free Radic Biol Med; 2015 Dec; 89():287-99. PubMed ID: 26409771 [TBL] [Abstract][Full Text] [Related]
23. A novel synthetic analog of Militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells. Yoon DH; Lim MH; Lee YR; Sung GH; Lee TH; Jeon BH; Cho JY; Song WO; Park H; Choi S; Kim TW Toxicol Appl Pharmacol; 2013 Dec; 273(3):659-71. PubMed ID: 24161344 [TBL] [Abstract][Full Text] [Related]
24. Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles. Muñoz-Gámez JA; López Viota J; Barrientos A; Carazo Á; Sanjuán-Nuñez L; Quiles-Perez R; Muñoz-de-Rueda P; Delgado Á; Ruiz-Extremera Á; Salmerón J Liver Int; 2015 Apr; 35(4):1430-41. PubMed ID: 24821649 [TBL] [Abstract][Full Text] [Related]
25. Effective and new potent drug combination: Histone deacetylase and Wnt/β-catenin pathway inhibitors in lung carcinoma cells. Akgun O; Erkisa M; Ari F J Cell Biochem; 2019 Sep; 120(9):15467-15482. PubMed ID: 31037769 [TBL] [Abstract][Full Text] [Related]
26. ω-Hydroxyundec-9-enoic acid induces apoptosis through ROS-mediated endoplasmic reticulum stress in non-small cell lung cancer cells. Yang KM; Kim BM; Park JB Biochem Biophys Res Commun; 2014 Jun; 448(3):267-73. PubMed ID: 24796672 [TBL] [Abstract][Full Text] [Related]
27. Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells. Zhu X; Wang K; Zhang K; Zhu L; Zhou F Toxicol Lett; 2014 May; 227(1):65-73. PubMed ID: 24680927 [TBL] [Abstract][Full Text] [Related]
28. Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling. Yin H; Zhou Y; Wen C; Zhou C; Zhang W; Hu X; Wang L; You C; Shao J Oncol Rep; 2014 Oct; 32(4):1610-6. PubMed ID: 25050915 [TBL] [Abstract][Full Text] [Related]
29. Erlotinib activates mitochondrial death pathways related to the production of reactive oxygen species in the human non-small cell lung cancer cell line A549. Qian X; Li J; Ding J; Wang Z; Zhang W; Hu G Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):487-94. PubMed ID: 19673930 [TBL] [Abstract][Full Text] [Related]
30. Reactive oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer. Song J; Shu L; Zhang Z; Tan X; Sun E; Jin X; Chen Y; Jia X Chem Biol Interact; 2012 Jul; 199(1):9-17. PubMed ID: 22687635 [TBL] [Abstract][Full Text] [Related]
31. Cepharanthine induces apoptosis through reactive oxygen species and mitochondrial dysfunction in human non-small-cell lung cancer cells. Hua P; Sun M; Zhang G; Zhang Y; Tian X; Li X; Cui R; Zhang X Biochem Biophys Res Commun; 2015 May; 460(2):136-42. PubMed ID: 25747710 [TBL] [Abstract][Full Text] [Related]
32. Investigation of the mechanism and apoptotic pathway induced by 4β cinnamido linked podophyllotoxins against human lung cancer cells A549. Kamal A; Nayak VL; Bagul C; Vishnuvardhan MV; Mallareddy A Apoptosis; 2015 Nov; 20(11):1518-29. PubMed ID: 26386574 [TBL] [Abstract][Full Text] [Related]
33. Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance. Yamauchi T; Ogawa M; Ueda T Mol Pharmacol; 2008 Jul; 74(1):82-91. PubMed ID: 18430789 [TBL] [Abstract][Full Text] [Related]
34. Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition. Viola G; Cecconet L; Leszl A; Basso G; Brun P; Salvador A; Dall'Acqua F; Diana P; Barraja P; Cirrincione G Cancer Chemother Pharmacol; 2009 Nov; 64(6):1235-51. PubMed ID: 19363609 [TBL] [Abstract][Full Text] [Related]
35. Verrucarin A induces apoptosis through ROS-mediated EGFR/MAPK/Akt signaling pathways in MDA-MB-231 breast cancer cells. Palanivel K; Kanimozhi V; Kadalmani B; Akbarsha MA J Cell Biochem; 2014 Nov; 115(11):2022-32. PubMed ID: 24963595 [TBL] [Abstract][Full Text] [Related]
36. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway. Wang R; Ma L; Weng D; Yao J; Liu X; Jin F Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028 [TBL] [Abstract][Full Text] [Related]
37. [Mechanism of temozolomide-induced anti-tumor effects on glioblastoma cells in vitro is via ROS-dependent SIRT1 signaling pathway]. Jiang Y; Sun Y; Yuan Y Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):734-8. PubMed ID: 23291065 [TBL] [Abstract][Full Text] [Related]
38. Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species. He F; Wang Q; Zheng XL; Yan JQ; Yang L; Sun H; Hu LN; Lin Y; Wang X Oncol Rep; 2012 Aug; 28(2):601-5. PubMed ID: 22665077 [TBL] [Abstract][Full Text] [Related]
39. Acovenoside A Induces Mitotic Catastrophe Followed by Apoptosis in Non-Small-Cell Lung Cancer Cells. El Gaafary M; Ezzat SM; El Sayed AM; Sabry OM; Hafner S; Lang S; Schmiech M; Syrovets T; Simmet T J Nat Prod; 2017 Dec; 80(12):3203-3210. PubMed ID: 29190084 [TBL] [Abstract][Full Text] [Related]
40. Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects. Xu M; Floyd HS; Greth SM; Chang WC; Lohman K; Stoyanova R; Kucera GL; Kute TE; Willingham MC; Miller MS Toxicol Appl Pharmacol; 2004 Mar; 195(2):232-46. PubMed ID: 14998688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]